← Back to Analyst Consensus 
LFCR Hold
LIFECORE BIOMEDICAL, INC. DE
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 2 downgrades / 0 reiterations from 2 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 29, 2026 | Barrington Research | downgrade | Outperform → Market Perform | — | 56% |
| Sep 28, 2026 | William Blair | downgrade | Outperform → Market Perform | — | 48% |
| Jun 16, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Apr 29, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Mar 27, 2026 | Barrington Research | maintain | Outperform → Outperform | — | 56% |
| Mar 24, 2026 | Barrington Research | maintain | Outperform → Outperform | $5.5 | 56% |
| Mar 17, 2026 | Barrington Research | upgrade | Market Perform → Outperform | $5.5 | 56% |
| Sep 4, 2025 | Keybanc | initiate | — → Sector Weight | $0 | 53% |
| May 21, 2025 | William Blair | initiate | — → Outperform | $0 | 48% |
| Jan 3, 2025 | Stephens & Co. | reiterate | Equal-Weight → Equal-Weight | $6 | 54% |
| Nov 22, 2024 | Craig-Hallum | maintain | Buy → Buy | $10 | 54% |
| Sep 5, 2024 | Craig-Hallum | initiate | — → Buy | $8 | 54% |
| Aug 28, 2024 | Barrington Research | downgrade | Outperform → Market Perform | $0 | 56% |
| Sep 1, 2023 | Barrington Research | maintain | Outperform → Outperform | $10 | 56% |
| Sep 1, 2023 | Stephens & Co. | maintain | Equal-Weight → Equal-Weight | $9 | 54% |
| Jun 2, 2023 | Barrington Research | maintain | Outperform → Outperform | $11 | 56% |
| May 24, 2023 | Barrington Research | maintain | Outperform → Outperform | $10 | 56% |
| Mar 21, 2023 | Barrington Research | maintain | — → Outperform | $8 | 56% |
| Mar 20, 2023 | Barrington Research | maintain | — → Outperform | $8 | 56% |
| Mar 20, 2023 | Stephens & Co. | downgrade | Overweight → Equal-Weight | $2 | 54% |
| Mar 17, 2023 | Stephens & Co. | reiterate | — → Overweight | $11 | 54% |
Price Target Trend
Apr 16, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days